CMND Clearmind Medicine Inc.

NEUTRAL Impact: 2/10 3
Horizon months Filed Jun 12, 2026 Processed 8d 11h ago SEC 0001475597-26-000079
Form 3 — initial insider ownership statement
Latest settled — T+1d
CMND ▼ -6.82% at T+1d
NEUTRAL call ✗ call lost -6.82% · α vs SPY -6.23% · entry $3.37 → $3.14
Next anchor: T+5d tomorrow
Last close $3.07 (close Jun 18) · -8.90% from $3.37 entry
Entry anchored
Jun 12, 03:59 PM ET
via Databento tick
T+1d
-6.82%
call -6.82% · α -6.23%
$3.14
settled 6d ago
T+5d
call — · α —
tomorrow
T+20d
call — · α —
in 22d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

HRT Financial LP filed a Form 3 initial statement of beneficial ownership of securities in Clearmind Medicine Inc. (CMND), disclosing ownership of 101,951 shares of common stock. As a routine insider holdings disclosure by an institutional LP, this filing is neutral for valuation and does not convey any material change in operations, financials, or strategy.

Actionable Insight

This Form 3 filing is routine and holds no actionable trading information. Monitor for subsequent insider trading activity (Form 4 filings) by HRT Financial LP, which could signal changes in conviction. Given CMND's small market cap (~$3M), any material insider buying or selling could disproportionately move the stock.

Key Facts

  • Filing type: Form 3 (initial statement of beneficial ownership)
  • Reporting owner: HRT Financial LP, a Delaware limited partnership
  • Issuer: Clearmind Medicine Inc. (CMND), a pharmaceutical preparations company
  • HRT Financial LP beneficially owns 101,951 shares of CMND common stock
  • Date of event requiring statement: 2026-06-10
  • Filed on 2026-06-12 with SEC

Financial Impact

No financial impact. The filing is a regulatory disclosure of existing beneficial ownership, not a transaction or event that changes the company's financials.

Risk Factors

  • No material risks identified from this filing — it is purely a beneficial ownership disclosure

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001475597-26-000079
Document: 0001475597-26-000079-index.html0001475597-26-000079
Document: 0001475597-26-000079.txt0001475597-26-000079
36 reports for CMND
Performance horizon
50% Hit rate 6 of 12 directional calls best @ T+20▲ +71.18%Apr 20, 2026
Filters
Rows
Reports for CMND — sortable, filterable
Type Now
Jun 18, 2026
2d ago
6-K
NEUTRAL ★ 4/10
$3.07 awaiting T+1awaiting T+1$3.07 (−0.00%)
Jun 18, 2026
2d ago
Press Release
NEUTRAL ★ 3/10
$3.05 awaiting T+1awaiting T+1$3.07 (+0.66%)
Jun 16, 2026
4d ago
6-K
NEUTRAL ★ 4/10
$3.14 $3.14· 0.00%▲ +1.25%$3.07 (−2.23%)
Jun 12, 2026
8d ago
3
NEUTRAL ★ 2/10
$3.37 $3.14▼ −6.82%▼ −6.23%$3.07 (−8.90%)
Jun 5, 2026
15d ago
Press Release
NEUTRAL ★ 2/10
$3.98 $3.79▼ −4.77%▼ −5.00%$3.07 (−22.86%)
May 29, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$3.58 $3.17▼ −11.45%▼ −11.73%$3.07 (−14.25%)
May 29, 2026
22d ago
Press Release
NEUTRAL ★ 3/10
$3.58 $3.17▼ −11.45%▼ −11.73%$3.07 (−14.25%)
May 26, 2026
25d ago
6-K
NEUTRAL ★ 4/10
$2.59 $2.48▼ −4.25%▼ −4.26%$3.07 (+18.53%)
May 26, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$2.59 $2.48▼ −4.25%▼ −4.26%$3.07 (+18.53%)
May 19, 2026
4w ago
6-K
BEARISH ★ 6/10
$2.36 $2.52▼ −6.78%▼ −5.74%$3.07 (−30.08%)
Showing 10 of 36

US Market Status

Market Closed — Opens Mon (29h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access